Overview Cardiex Limited (ASX:CDX) is an ASX-listed medical technology company leveraging its proprietary SphygmoCor® technology to develop and market vascular biomarker technologies and digital solutions focused on the world’s largest health disorders. The company’s groundbreaking technology – SphygmoCor® – set the benchmark for noninvasive measurement of central aortic pressures and…
Overview Impact Minerals (ASX:IPT) is an exploration and development mining company focused on discovering and developing new resource projects…
(TheNewswire) Payment date for the distribution will be April 26, 2024 Coquitlam, BC TheNewswire – April 18, 2024 –…
Victory Battery Metals CORP. (CSE:VR)(OTC PINK:VRCFF)(FWB:VR6) is pleased to announce that it has entered into an option agreement dated…
/NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES / Awalé Resources (TSXV:…
Vizsla Copper Corp. (TSXV: VCU) (‘ Vizsla Copper ‘) and Universal Copper Ltd. (TSXV: UNV) (‘ Universal Copper ‘)…
Overview Countries worldwide are working towards decarbonization and paying more attention to clean energy sources. About 10 percent of…
In terms of gold, he believes US$2,500 per ounce is a ‘lock’ in 2024, with US$3,000 possible within 12…